Compare BCAB & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCAB | ITRG |
|---|---|---|
| Founded | 2007 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 482.5M |
| IPO Year | 2020 | N/A |
| Metric | BCAB | ITRG |
|---|---|---|
| Price | $0.80 | $4.27 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $1.00 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 2.1M | 1.7M |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $219,125,000.00 |
| Revenue This Year | N/A | $1,016.77 |
| Revenue Next Year | N/A | $7.81 |
| P/E Ratio | ★ N/A | $54.14 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.24 | $0.79 |
| 52 Week High | $1.53 | $4.36 |
| Indicator | BCAB | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 47.86 | 74.47 |
| Support Level | $0.79 | $3.53 |
| Resistance Level | $0.90 | $3.99 |
| Average True Range (ATR) | 0.09 | 0.20 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 23.68 | 90.13 |
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.